This is an application for continued funding of the University of California, Davis Alzheimer's Disease Center (UCD ADC). The overall goal of the Center is to promote research on Alzheimer's disease (AD) throughout Northern California. More specifically, the ADC will continue to develop and provide a research infrastructure to promote investigator interaction, facilitate subject recruitment for individual investigators, and create research resources including a subject pool, a database, and a tissue bank. The Clinical Core will draw patients from a number of existing clinics, including two California Alzheimer's Disease Diagnostic and Treatment Centers (ADDTCs) in Sacramento and Berkeley as well as VA, county, and University clinics, to provide a large, ethnically diverse group of dementia patients representative of the population of Northern California. All patients will be evaluated at either the Sacramento or Berkeley sites, or at a Satellite clinic closely tied to one of these parent sites. A number of methods have been developed to assure high quality and reliable data. Clinical data, comprising the results of demographic information, history, physical and neurological examination, cognitive and behavioral assessments, and neuroimaging data will be entered into an electronic database. Annual reevaluations will be performed on all patients meeting criteria for inclusion into the longitudinal research cohort. Matched control subjects will undergo the identical evaluations and will be followed longitudinally. The Neuropathology Core will obtain neuropathological examinations on patients and controls who have been followed longitudinally. Autopsy services will be provided through mechanisms permitting brain removal by rapidly dispatched dissectors able to process tissue locally, with transport to Davis for neuropathological evaluation. These neuropathological data will also be entered into the data base and both the data and tissue made available to investigators. The Administrative Core has developed a formal structure to advise the principal investigator on the allocation of center resources and the effective integration of all core and research components of the center. The Center Executive Committee is the principal decision making body of the center, with additional advice provided by an intramural University Advisory Committee, an External Advisory Committee, an ad hoc Pilot Grant Review Committee, and a Community Advisory Committee. The Information Transfer Core will enhance the collective functions of the ADC by training new clinicians and investigators, promoting and disseminating ADC activities to the University, the Northern California Alzheimer Research community and caregivers, and by providing a number of formal mechanisms for increasing interactions between clinicians, researchers, and members of the academic community.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1 (30))
Program Officer
Phelps, Creighton H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Davis
Schools of Medicine
United States
Zip Code
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Jena, Prasant Kumar; Sheng, Lili; Di Lucente, Jacopo et al. (2018) Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity. FASEB J 32:2866-2877
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Maezawa, Izumi; Nguyen, Hai M; Di Lucente, Jacopo et al. (2018) Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Brain 141:596-612
Meyer, Oanh L; Liu, Xiaoyan Lucia; Tancredi, Daniel et al. (2018) Acculturation level and caregiver outcomes from a randomized intervention trial to enhance caregivers' health: evidence from REACH II. Aging Ment Health 22:730-737
Fletcher, Evan; Gavett, Brandon; Harvey, Danielle et al. (2018) Brain volume change and cognitive trajectories in aging. Neuropsychology 32:436-449
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Dadar, Mahsa; Maranzano, Josefina; Ducharme, Simon et al. (2018) Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging. Hum Brain Mapp 39:1093-1107
Wong, Jonathan M; Gray, John A (2018) Long-Term Depression Is Independent of GluN2 Subunit Composition. J Neurosci 38:4462-4470

Showing the most recent 10 out of 1156 publications